Floatz logo

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

M.D. Anderson Cancer Centerother_biologicalPhase 2Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
65/ 100

Competitive context

202 Active assets in the Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cohort.

Asset / SponsorPhaseRating
Etoposide
Weill Medical College of Cornell University
Phase 2BBB
Lisaftoclax
Henan Cancer Hospital
Phase 3BBB
CHLORAMBUCIL
Ascentage Pharma Group Inc.
Phase 4BBB
Prednisone
AstraZeneca
Phase 3BBB
Irinotecan
IGM Biosciences, Inc.
Phase 2BBB

View all 50 →

Same molecule, other indications

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT is also rated in:

myelodysplastic/myeloproliferative neoplasmActive
BBB
Indicative · Phase 2/3
75 / 100
View asset →
plasma cell myelomaActive
BBB
Indicative · Phase 4
72 / 100
View asset →
myeloproliferative neoplasmActive
BB
Indicative · Phase 2/3
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →